However, chemotherapy can increase miR expression in cancer cells [32,33,34,35,36], and, therefore, the use of FOLFOXIRI drugs could potentially lead to an undesirable reduction in viral replication of miR-TS-containing oncolytic CVB3 in CRC cells. Here, TYMS is linked to cancer.